Isolate code | Origin | Antibiotic resistance patterns | No. of antimicrobial classes | ESBL† | KPC‡ |
---|---|---|---|---|---|
** UPEC 2 | F | AM, CEFT, CEFE, TS | 3 | – | – |
** UPEC 6 | F | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
** UPEC 12 | F | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
** UPEC 13 | F | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
** UPEC 17 | M | AM, CEFT, CEFE, CIP, TS | 4 | – | – |
UPEC 20 | F | NOR | 1 | – | – |
** UPEC 25 | F | AM, AC, PT*, CIP, NOR, NIT* | 3 | – | – |
** UPEC 32 | F | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
** UPEC 39 | M | AM, CEFT, CEFE, NIT | 3 | + | + |
** UPEC 45 | M | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
UPEC 88 | F | AM, NOR | 2 | – | – |
** UPEC 95 | F | AM, CEFT, CEFE, NOR, TS | 4 | + | + |
** UPEC 119 | F | AM, CEFT, CEFE, NOR | 3 | + | + |
UPEC 127 | M | NOR | 1 | – | – |
UPEC 138 | F | NOR | 1 | – | – |
UPEC 145 | F | NOR | 1 | – | – |
UPEC 151 | F | NOR | 1 | – | – |
UPEC 156 | M | NOR | 1 | – | – |
UPEC 168 | F | NOR | 1 | – | – |
** UPEC 192 | M | AM, CEFT, CEFE, NOR, TS | 4 | + | + |
** UPEC 213 | M | AM, CEFT, CEFE, CIP, NOR, TS | 4 | + | + |
** UPEC 225 | M | AM, G, CIP, NOR, TS | 4 | – | – |
UPEC 226 | M | NOR | 1 | – | – |
UPEC 230 | M | NOR | 1 | – | – |
UPEC 242 | M | NOR | 1 | – | – |
** UPEC 243 | F | AM, G, CIP, NOR, TS, NIT* | 4 | – | – |
** UPEC 316 | F | AM, CEFT, CEFE, G, CIP, NOR, TS | 5 | + | + |
** UPEC 326 | F | AM, CEFT, CEFE, G, CIP, NOR, TS | 5 | + | + |
UPEC 331 | M | NOR | 1 | – | – |
** UPEC 353 | F | AM, CEFT, CEFE, TS | 3 | + | – |
** UPEC 425 | M | AM, AC, PT, NOR, TS | 3 | – | – |
UPEC 432 | M | NOR | 1 | – | – |
** UPEC 450 | M | AM, AC*, CEFT, CEFE, G, CIP, NOR, TS | 5 | + | + |
** UPEC 544 | F | AM, AC*, G, NOR, TS | 4 | – | – |
** UPEC 549 | M | AM, CEFT, CEFE, CIP, TS | 4 | + | + |
** UPEC 661 | F | AM, CEFT, CEFE, TS | 3 | + | + |
UPEC 662 | F | AM | 1 | – | – |
UPEC 666 | F | AM, CEFT, CEFE | 2 | + | + |
UPEC 738 | M | AM | 1 | – | – |
UPEC 829 | F | AM, TS | 2 | – | – |
UPEC 950 | M | AM, TS | 2 | – | – |
UPEC 1000 | M | AM, NIT | 2 | + | + |
Isolates origin | Total number of UPEC | ESBL+† (%) | ESBL+‡ (%) | KPC+ (%) | β-hemolysis (%) |
---|---|---|---|---|---|
Male | 22 | 7 (32) | 7 (32) | 7 (32) | 11 (50) |
Female | 28 | 11 (39.3) | 11 (39.3) | 10 (36) | 16 (57.2) |
Total | 50 | 18 (36) | 18 (36) | 17 (34) | 27 (54) |
Biofilm formation ability | Range | Negative control | ||
---|---|---|---|---|
Strong (S) | Moderate (M) | Weak (W) | ||
BF = AB– CW | ≥ 0.200 – 0.299 | 0.100 – 0.199 | < 0.100 | < 0.100 |
BF = AB ÷ CW | 4.00 – 5.99 | 2.00 – 3.99 | < 2.00 – 1.00 | < 1.00 |
Isolate code | BF† | BF‡ | AMR |
---|---|---|---|
UPEC (2) | N (0.058) | W (1.167) | 3 |
UPEC (6) | M (0.185) | N (0.420) | 4 |
UPEC (12) | S (0.343) | W (1.988) | 4 |
UPEC (13) | S (0.365) | M (2.051) | 4 |
UPEC (17) | N (0.066) | W (1.190) | 4 |
UPEC (20) | S (0.313) | W (1.902) | 1 |
UPEC (25) | M (0.121) | W (1.348) | 2 |
UPEC (32) | N (0.067) | W (1.193) | 4 |
UPEC (39) | W (0.39) | M (2.123) | 2 |
UPEC (45) | N (0.086) | W (1.247) | 4 |
UPEC (88) | N (0.066) | W (1.190) | 2 |
UPEC (95) | N (0.086) | W (1.247) | 4 |
UPEC (119) | N (0.046) | W (1.132) | 4 |
UPEC (127) | S (0.339) | W (1.976) | 1 |
UPEC (138) | S (0.239) | W (1.688) | 1 |
UPEC (145) | M (0.151) | W (1.435) | 1 |
UPEC (151) | M (0.135) | W (1.389) | 1 |
UPEC (156) | W (0.057) | W (1.164) | 1 |
UPEC (168) | W (0.031) | W (1.089) | 1 |
UPEC (192) | W (0.034) | W (1.097) | 4 |
UPEC (213) | W (0.074) | W (1.213) | 4 |
UPEC (225) | M (0.187) | W (1.538) | 4 |
UPEC (226) | M (0.121) | W (1.348) | 1 |
UPEC (230) | N (0.068) | W (1.178) | 1 |
UPEC (242) | N (–0.015) | N (0.960) | 1 |
UPEC (243) | N (0.062) | W (1.162) | 4 |
UPEC (316) | N (0.016) | W (1.041) | 5 |
UPEC (326) | N (–0.027) | N (0.929) | 5 |
UPEC (331) | N (0.004) | W (1.010) | 1 |
UPEC (353) | N (0.031) | W (1.081) | 3 |
UPEC (425) | N (–0.017) | N (0.955) | 3 |
UPEC (432) | N (0.027) | W (1.070) | 1 |
UPEC (450) | N (0.054) | W (1.141) | 5 |
UPEC (544) | N (0.061) | W (1.159) | 4 |
UPEC (549) | S (0.216) | W (1.565) | 4 |
UPEC (601) | N (0.024) | W (1.062) | 0 |
UPEC (654) | N (0.013) | W (1.034) | 0 |
UPEC (661) | N (0.088) | W (1.230) | 3 |
UPEC (662) | M (0.125) | W (1.327) | 1 |
UPEC (666) | N (0.068) | W (1.178) | 2 |
UPEC (704) | S (0.328) | W (1.858) | 0 |
UPEC (738) | N (–0.017) | N (0.955) | 1 |
UPEC (829) | N (–0.027) | N (0.929) | 2 |
UPEC (842) | N (0.074) | W (1.193) | 0 |
UPEC (848) | S (0.379) | W (1.992) | 0 |
UPEC (882) | N (0.09) | W (1.235) | 0 |
UPEC (900) | N (0.068) | W (1.190) | 0 |
UPEC (928) | N (0.074) | W (1.193) | 0 |
UPEC (950) | M (0.121) | W (1.348) | 2 |
UPEC (1000) | M (0.121) | W(1.338) | 2 |
–0.0948 | –0.1475 | NS |
Gene/ primer | Sequence | Product size (bp) | Annealing temperature |
---|---|---|---|
FP: 5'–GCGCATTTGCTGATACTGTTG-3' |
270 | 62 | |
FP: 5'–GGTGTGGTGCGATGAGCACAG-3' |
288 | 62 | |
FP: 5'–TCAGAAGCTCAGCGAATCATTG-3' |
931 | 59 | |
FP: 5'–GGCGGAAATGGTTCAGATGTTG-3' |
301 | 60 | |
FP: 5'–AACGGTTGGTGGCAACAATCC-3' |
418 | 58 | |
FP: 5'–GGCTGGACATCATGGGAACTGG-3' |
302 | 85 | |
FP: 5'–GATACCACGTTCCGTCTGG-3' |
246 | 50-60 | |
FP: 5'–TTTGCGATGTGCAGTACCAGTAA-3' |
544 | 62 |
Sample origin | N | P (%) | AM | AC | PT | CEFT | CEFE | ERT | IMI | MER | AMI | G | CIP | NOR | NIT | TS |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | 774 | 22 (2.84) | 12 | 1, (1*) | 1 | 7 | 7 | 0 | 0 | 0 | 0 | 2 | 6 | 19 | 2 | 9 |
Female | 226 | 28 (12.4) | 18 | 1, (1*) | (1*) | 12 | 12 | 0 | 0 | 0 | 0 | 4 | 8 | 22 | (2*) | 13 |
Total | 1,000 | 50 (5) | 30 | 4 | 2 | 19 | 19 | 0 | 0 | 0 | 0 | 6 | 14 | 41 | 4 | 22 |
< 0.001 |
Isolates origin | Total number of UPEC | Genes encoding for virulence factors | |||||
---|---|---|---|---|---|---|---|
Male | 22 | 22 (100) | 22 (100) | 22 (100) | 22 (100) | 22 (100) | 9 (41) |
Female | 28 | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 27 (97) | 10 (36) |
Total | 50 | 50 (100) | 50 (100) | 50 (100) | 50 (100) | 49 (98) | 19 (38) |
Genes encoding for antimicrobial resistance | |||||||
Male | 22 | 8 (37) | 7 (32) | ||||
Female | 28 | 10 (36) | 5 (18) | ||||
Total | 50 | 18 (36) | 12 (24) |